Fmr LLC Arcturus Therapeutics Holdings Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Fmr LLC holds 181,626 shares of ARCT stock, worth $3.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

181,626

Previous 262,010 30.68%

Holding current value

$3.87 Million

Previous $2.77 Million 14.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.91 - $14.41 $716,221 - $1.16 Million	-80,384 Reduced 30.68%	181,626 $2.36 Million
Q1 2025 May 12, 2025	SELL	$10.59 - $20.83 $1.98 Million - $3.89 Million	-186,801 Reduced 41.62%	262,010 $2.77 Million
Q4 2024 Feb 13, 2025	BUY	$14.82 - $25.48 $86,000 - $147,860	5,803 Added 1.31%	448,811 $7.62 Million
Q3 2024 Nov 13, 2024	SELL	$18.08 - $25.38 $2.03 Million - $2.86 Million	-112,516 Reduced 20.25%	443,008 $10.3 Million
Q2 2024 Aug 13, 2024	SELL	$24.35 - $44.39 $1.62 Million - $2.94 Million	-66,334 Reduced 10.67%	555,524 $13.5 Million
Q1 2024 May 13, 2024	SELL	$31.23 - $42.99 $7.57 Million - $10.4 Million	-242,500 Reduced 28.06%	621,858 $21 Million
Q4 2023 Feb 13, 2024	SELL	$17.71 - $32.97 $1.34 Million - $2.5 Million	-75,923 Reduced 8.07%	864,358 $27.3 Million
Q3 2023 Nov 13, 2023	BUY	$25.44 - $37.35 $1.88 Million - $2.77 Million	74,081 Added 8.55%	940,281 $24 Million
Q2 2023 Aug 11, 2023	BUY	$23.94 - $32.36 $905,123 - $1.22 Million	37,808 Added 4.56%	866,200 $24.8 Million
Q1 2023 May 11, 2023	SELL	$14.72 - $23.97 $1.2 Million - $1.96 Million	-81,851 Reduced 8.99%	828,392 $19.9 Million
Q4 2022 Feb 13, 2023	SELL	$14.14 - $23.06 $623,319 - $1.02 Million	-44,082 Reduced 4.62%	910,243 $15.4 Million
Q3 2022 Nov 10, 2022	BUY	$13.05 - $22.13 $438,062 - $742,859	33,568 Added 3.65%	954,325 $14.1 Million
Q2 2022 Aug 12, 2022	SELL	$12.26 - $31.17 $478 - $1,215	-39 Reduced -0.0%	920,757 $14.5 Million
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $4,798 - $10,763	272 Added 0.03%	920,796 $24.8 Million
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $5.21 Million - $7.25 Million	-152,453 Reduced 14.21%	920,524 $34.1 Million
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $9.55 Million - $20 Million	342,687 Added 46.92%	1,072,977 $51.3 Million
Q2 2021 Aug 13, 2021	BUY	$25.79 - $42.11 $18.8 Million - $30.8 Million	730,290 New	730,290 $24.7 Million

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $567M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account